Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6844-6859
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6844
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6844
Figure 4 Effects of the Na+/K+/2Cl- cotransporter blocker furosemide on the proliferation of TE9, TE13 and KYSE70 cells.
Cell number was counted 72 h after drug stimulation (500 μmol/L furosemide). The mean ± SEM. n = 3. aP < 0.05 vs control (significantly different from 500 μmol/L DMSO).
- Citation: Shiozaki A, Nako Y, Ichikawa D, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Marunaka Y, Otsuji E. Role of the Na+/K+/2Cl- cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma. World J Gastroenterol 2014; 20(22): 6844-6859
- URL: https://www.wjgnet.com/1007-9327/full/v20/i22/6844.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i22.6844